Pitts D K, Beuthin F C, Commissaris R L
Eur J Pharmacol. 1986 May 13;124(1-2):67-74. doi: 10.1016/0014-2999(86)90125-1.
The present studies examined the role of alpha 1- versus alpha 2-adrenoceptors in the cardiovascular effects of clonidine administered into the anterior hypothalamic/pre-optic (AH/PO) region of the forebrain by the push-pull perfusion technique. Push-pull cannulas were placed bilaterally into the AH/PO region of anesthetized, paralyzed and ventilated rats. Perfusion of this area with artificial CSF (0.015 ml/min), yohimbine (5 or 50 microM) for 30 min did not affect mean arterial blood pressure or heart rate. Perfusion of the AH/PO region with clonidine (0.55-5.50 mM) resulted in a concentration-dependent reduction of mean arterial pressure and heart rate. The hypotensive effects of clonidine were found to be greater than the bradycardic effects, when expressed as a percent of pre-infusion baseline values. Co-perfusion with yohimbine (5, 50 microM) significantly attenuated the hypotensive, but not the bradycardic, effects of a single concentration (1.75 mM) of clonidine; this selective antagonism of the hypotensive effect of clonidine by yohimbine was concentration dependent. In contrast to yohimbine, co-perfusion with 5 microM prazosin did not significantly affect either the clonidine-induced hypotension or bradycardia. Co-perfusion with the higher concentration (50 microM) of prazosin significantly reversed the bradycardic, but not the hypotensive, effects of 1.75 mM clonidine. These results suggest that AH/PO clonidine perfusion depresses both mean arterial pressure and heart rate, and that the clonidine-induced hypotension is due to alpha 2-adrenoceptor activation, while the clonidine-induced bradycardia is due to alpha 1-adrenoceptor activation.
本研究通过推挽灌注技术,研究了α1-肾上腺素能受体与α2-肾上腺素能受体在前脑下丘脑前部/视前区(AH/PO)注射可乐定后心血管效应中的作用。将推挽套管双侧置于麻醉、瘫痪并通气的大鼠的AH/PO区。用人工脑脊液(0.015 ml/分钟)、育亨宾(5或50微摩尔)灌注该区域30分钟,未影响平均动脉血压或心率。用可乐定(0.55 - 5.50毫摩尔)灌注AH/PO区导致平均动脉压和心率呈浓度依赖性降低。以输注前基线值的百分比表示时,可乐定的降压作用大于减慢心率的作用。与育亨宾(5、50微摩尔)共同灌注可显著减弱单一浓度(1.75毫摩尔)可乐定的降压作用,但不减弱其减慢心率的作用;育亨宾对可乐定降压作用的这种选择性拮抗作用呈浓度依赖性。与育亨宾相反,与5微摩尔哌唑嗪共同灌注对可乐定诱导的低血压或心动过缓均无显著影响。与较高浓度(50微摩尔)的哌唑嗪共同灌注可显著逆转1.75毫摩尔可乐定的减慢心率作用,但不能逆转其降压作用。这些结果表明,AH/PO区灌注可乐定可降低平均动脉压和心率,且可乐定诱导的低血压是由于α2-肾上腺素能受体激活,而可乐定诱导的心动过缓是由于α1-肾上腺素能受体激活。